Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    June 2018
  1. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed     Text format    


  2. MCBRIDE B, Mitra S, Kondo V, Elmi H, et al
    Unpaid labour, #MeToo, and young women in global health.
    Lancet. 2018;391:2192-2193.
    PubMed     Text format    


    May 2018
  3. NISHTAR S, Niinisto S, Sirisena M, Vazquez T, et al
    Time to deliver: report of the WHO Independent High-Level Commission on NCDs.
    Lancet. 2018 May 31. pii: S0140-6736(18)31258.
    PubMed     Text format    


  4. ZAROCOSTAS J
    HIV/AIDS community divided over allegations about UNAIDS.
    Lancet. 2018;391:1984.
    PubMed     Text format    


    April 2018

  5. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Lancet. 2018 Apr 17. pii: S0140-6736(18)30698.
    PubMed     Text format     Abstract available


    March 2018
  6. OLAKUNDE BO, Adeyinka DA, Wakdok SS, Oladele TT, et al
    Quantification of the effect of terrorism on the HIV response in Nigeria.
    Lancet. 2018;391:1257-1258.
    PubMed     Text format    


  7. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    


  8. BROWNE JL, Smit MR, Angira F, van der Graaf R, et al
    Good intentions do not replace ethical conduct in research.
    Lancet. 2018;391:1020-1021.
    PubMed     Text format    


    February 2018
  9. THAPA S
    Women helping women prevent HIV in resource-limited settings.
    Lancet. 2018;391:738-739.
    PubMed     Text format    


    January 2018
  10. LLIBRE JM, Hung CC, Brinson C, Castelli F, et al
    Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
    Lancet. 2018 Jan 5. pii: S0140-6736(17)33095.
    PubMed     Text format     Abstract available


  11. BICCARD BM, Madiba TE, Kluyts HL, Munlemvo DM, et al
    Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study.
    Lancet. 2018 Jan 3. pii: S0140-6736(18)30001.
    PubMed     Text format     Abstract available


    December 2017
  12. BERNARDO EL, Fuente-Soro L, Lopez-Varela E, Naniche D, et al
    Anonymity in HIV testing: implications for public health.
    Lancet. 2017;390:2546.
    PubMed     Text format    


    October 2017
  13. LAMONTAGNE F, Fowler RA, Adhikari NK, Murthy S, et al
    Evidence-based guidelines for supportive care of patients with Ebola virus disease.
    Lancet. 2017 Oct 17. pii: S0140-6736(17)31795.
    PubMed     Text format     Abstract available


  14. IYER JK, Mendelson M
    Can the Antimicrobial Resistance Benchmark blaze a new trail?
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32670.
    PubMed     Text format    


    September 2017
  15. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


  16. KAZATCHKINE MD
    Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.
    Lancet. 2017;390:1611-1612.
    PubMed     Text format    



  17. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1151-1210.
    PubMed     Text format     Abstract available



  18. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1084-1150.
    PubMed     Text format     Abstract available


    August 2017
  19. SAX PE, Pozniak A, Montes ML, Koenig E, et al
    Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-infer
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32340.
    PubMed     Text format     Abstract available


  20. BOFFITO M, Venter F
    The triumph of HIV treatment: another new antiretroviral.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32297.
    PubMed     Text format    


  21. GALLANT J, Lazzarin A, Mills A, Orkin C, et al
    Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32299.
    PubMed     Text format     Abstract available


  22. GREEN A
    President of Zambia declares HIV testing mandatory.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32295.
    PubMed     Text format    


  23. THE LANCET
    Losing the fight against HIV in the Philippines.
    Lancet. 2017;390:626.
    PubMed     Text format    


    July 2017
  24. KARIM SSA, Karim QA, Abimiku A, Bekker LG, et al
    Closing the NIH Fogarty Center threatens US and global health.
    Lancet. 2017;390:451.
    PubMed     Text format    


  25. HODSON N, Bewley S
    Nelly Mugo and the response to HIV: more than just PrEP advocacy.
    Lancet. 2017;390:358.
    PubMed     Text format    


  26. GREEN A
    The HIV response in Ukraine: at a crossroads.
    Lancet. 2017;390:347-348.
    PubMed     Text format    


  27. BEYRER C, Das P, Horton R, Ryan O, et al
    The International AIDS Society-Lancet Commission on the future of the HIV response and global health.
    Lancet. 2017;390:344-345.
    PubMed     Text format    


  28. GRANICH R, Williams B, Montaner J, Zuniga JM, et al
    90-90-90 and ending AIDS: necessary and feasible.
    Lancet. 2017;390:341-343.
    PubMed     Text format    


  29. THE LANCET
    The global HIV/AIDS epidemic-progress and challenges.
    Lancet. 2017;390:333.
    PubMed     Text format    


  30. BOYD MA, Cooper DA
    Long-acting injectable ART: next revolution in HIV?
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31962.
    PubMed     Text format    


  31. MARGOLIS DA, Gonzalez-Garcia J, Stellbrink HJ, Eron JJ, et al
    Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31917.
    PubMed     Text format     Abstract available


    March 2017
  32. DANIELS JP
    Venezuela's economic crisis hampers HIV/AIDS treatment.
    Lancet. 2017;389:1088-1089.
    PubMed     Text format    


  33. HUFFMAN MD, Xavier D, Perel P
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet. 2017;389:1055-1065.
    PubMed     Text format     Abstract available


  34. MENDENHALL E, Kohrt BA, Norris SA, Ndetei D, et al
    Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.
    Lancet. 2017;389:951-963.
    PubMed     Text format     Abstract available


  35. MOHAMMADI D
    Growing older with HIV in the UK.
    Lancet. 2017;389:894-895.
    PubMed     Text format    


    February 2017
  36. DOWNS JA, Mwakisole AH, Chandika AB, Lugoba S, et al
    Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial.
    Lancet. 2017 Feb 14. pii: S0140-6736(16)32055.
    PubMed     Text format     Abstract available


    January 2017
  37. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


  38. SHIELS MS, Chernyavskiy P, Anderson WF, Best AF, et al
    Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.
    Lancet. 2017 Jan 25. pii: S0140-6736(17)30187.
    PubMed     Text format     Abstract available


  39. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available


    December 2016
  40. ZHU FC, Wurie AH, Hou LH, Liang Q, et al
    Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32617.
    PubMed     Text format     Abstract available


  41. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Text format     Abstract available


    November 2016
  42. DAS P
    Deborah L Birx: on a mission to end the HIV/AIDS epidemic.
    Lancet. 2016;388:2583.
    PubMed     Text format    


  43. KIRBY T
    Targeting HIV prevention to young women in Africa.
    Lancet. 2016;388:2579.
    PubMed     Text format    


  44. KIRBY T
    David Cooper: Australia's fighter against HIV and discrimination.
    Lancet. 2016;388:2469.
    PubMed     Text format    


  45. YANG YT, Wiley E, Duvivier RJ
    US policy on blood donation by men who have sex with men.
    Lancet. 2016;388:2236-2237.
    PubMed     Text format    


    October 2016
  46. HONORE JG, Balan JG, Thimothe G, Diallo J, et al
    Instability adversely affects HIV care in Haiti.
    Lancet. 2016;388:1877.
    PubMed     Text format    


  47. GREEN A
    NIH project focuses on integration of HIV and NCD care.
    Lancet. 2016;388:1869.
    PubMed     Text format    



  48. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1775-1812.
    PubMed     Text format     Abstract available



  49. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1545-1602.
    PubMed     Text format     Abstract available



  50. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1459-1544.
    PubMed     Text format     Abstract available


  51. QIN Y, Liu F, Tang W, Tang S, et al
    HIV self-testing among high-risk men who have sex with men in China: a cross-sectional study.
    Lancet. 2016;388 Suppl 1:S76.
    PubMed     Text format     Abstract available


  52. MAO J, Tang W, Liu C, Wong NS, et al
    Sex tourism among Chinese men who have sex with men: a cross-sectional observational study.
    Lancet. 2016;388 Suppl 1:S75.
    PubMed     Text format     Abstract available


  53. TANG S, Tang W, Meyers K, Chan P, et al
    HIV and syphilis among men who have sex with men and transgender individuals in China: a scoping review.
    Lancet. 2016;388 Suppl 1:S74.
    PubMed     Text format     Abstract available


  54. TANG W, Mao J, Liu C, Mollan K, et al
    Crowdsourcing health communication about condom use in men who have sex with men in China: a randomised controlled trial.
    Lancet. 2016;388 Suppl 1:S73.
    PubMed     Text format     Abstract available


  55. ZHAO P, Tang S, Wang C, Zhang Y, et al
    Recreational drug use among Chinese MSM: results from a national-wide cross-sectional study.
    Lancet. 2016;388 Suppl 1:S69.
    PubMed     Text format     Abstract available


  56. TANG W, Mao J, Tang S, Liu C, et al
    Disclosure of sexual orientation in men who have sex with men in China: a cross-sectional survey.
    Lancet. 2016;388 Suppl 1:S68.
    PubMed     Text format     Abstract available


  57. SMITH MK, Miller WC, Liu H, Ning C, et al
    Effects of patient load and travel distance on HIV transmission in a cohort of serodiscordant couples in rural China: a longitudinal analysis.
    Lancet. 2016;388 Suppl 1:S65.
    PubMed     Text format     Abstract available


  58. WONG NS, Wong KH, Tsang OT, Lee MP, et al
    HIV testing campaigns and treatment interventions for control of epidemic HIV growth among heterosexuals: a mathematical modelling study.
    Lancet. 2016;388 Suppl 1:S49.
    PubMed     Text format     Abstract available


  59. KWAN TH, Poon CM, Wong KH, Lee SS, et al
    Effects of HIV diagnosis and enrolment in care on transmission risk of HIV-infected men who have sex with men in Hong Kong: a cross-sectional study.
    Lancet. 2016;388 Suppl 1:S48.
    PubMed     Text format     Abstract available


  60. NING C, Smith KM, McCann CD, Hu F, et al
    Mortality and retention in hospital-based and CDC-based antiretroviral service delivery in people living with HIV in the Guangdong Province, China: a prospective cohort study.
    Lancet. 2016;388 Suppl 1:S26.
    PubMed     Text format     Abstract available


  61. WONG WC, Jiang S, Ong J, Peng M, et al
    Availability and use of primary care facilities in China: a nationwide representative survey.
    Lancet. 2016;388 Suppl 1:S18.
    PubMed     Text format     Abstract available


    September 2016
  62. HADLAND SE, Wood E, Levy S
    How the paediatric workforce can address the opioid crisis.
    Lancet. 2016;388:1260-1.
    PubMed     Text format    



  63. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.
    Lancet. 2016 Sep 19. pii: S0140-6736(16)31467.
    PubMed     Text format     Abstract available


  64. PAN SW, Li D, Carpiano RM, Spittal PM, et al
    Ethnicity and HIV epidemiology research in China.
    Lancet. 2016;388:1052-3.
    PubMed     Text format    


  65. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    


    August 2016
  66. CLARK F
    Gaps remain in Russia's response to HIV/AIDS.
    Lancet. 2016;388:857-8.
    PubMed     Text format    


  67. PERSAD GC, Emanuel EJ
    The ethics of expanding access to cheaper, less effective treatments.
    Lancet. 2016;388:932-4.
    PubMed     Text format    


  68. POKU NK
    UN political declaration on HIV and AIDS: where to begin?
    Lancet. 2016;388:743-744.
    PubMed     Text format    



  69. NHS England: preparing for PrEP.
    Lancet. 2016;388:634.
    PubMed     Text format    



  70. Reassessing blood donation by men who have sex with men.
    Lancet. 2016;388:534.
    PubMed     Text format    


  71. KROIDL I, Saathof E, Maganga L, Makunde WH, et al
    Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study.
    Lancet. 2016 Aug 2. pii: S0140-6736(16)31252.
    PubMed     Text format     Abstract available


  72. DOWNS JA, Fitzgerald DW
    No more neglect of helminths and HIV.
    Lancet. 2016 Aug 2. pii: S0140-6736(16)31253.
    PubMed     Text format    


    July 2016
  73. RUBIN R
    US prisons missing opportunities to tackle HIV in inmates.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)31078.
    PubMed     Text format    


  74. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available


  75. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available


  76. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available


  77. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


  78. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  79. SHRAGE L
    African Americans, HIV, and mass incarceration.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30830.
    PubMed     Text format    


  80. DAS P, Horton R
    On both sides of the prison walls-prisoners and HIV.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30892.
    PubMed     Text format    


  81. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    PubMed     Text format     Abstract available


  82. BEYRER C, Kamarulzaman A, McKee M
    Prisoners, prisons, and HIV: time for reform.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30829.
    PubMed     Text format    


  83. BEYRER C, Baral SD, Collins C, Richardson ET, et al
    The global response to HIV in men who have sex with men.
    Lancet. 2016;388:198-206.
    PubMed     Text format     Abstract available


  84. WIKTOR SZ, Hutin YJ
    The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.
    Lancet. 2016 Jul 6. pii: S0140-6736(16)31018.
    PubMed     Text format    


    June 2016
  85. WYLIE K, Knudson G, Khan SI, Bonierbale M, et al
    Serving transgender people: clinical care considerations and service delivery models in transgender health.
    Lancet. 2016 Jun 16. pii: S0140-6736(16)00682.
    PubMed     Text format     Abstract available


  86. REISNER SL, Poteat T, Keatley J, Cabral M, et al
    Global health burden and needs of transgender populations: a review.
    Lancet. 2016 Jun 16. pii: S0140-6736(16)00684.
    PubMed     Text format     Abstract available


  87. GUISE A
    Next generation of comprehensive HIV prevention.
    Lancet. 2016;387:2377-8.
    PubMed     Text format    


  88. SIDIBE M, Singh PK
    Thailand eliminates mother-to-child transmission of HIV and syphilis.
    Lancet. 2016 Jun 9. pii: S0140-6736(16)30787.
    PubMed     Text format    


    May 2016
  89. LOMBARD C, Cousens S, Tylleskar T, Van de Perre P, et al
    Trial size, HIV pre-exposure prophylaxis, and breastfeeding - Authors' reply.
    Lancet. 2016;387:2091.
    PubMed     Text format    


  90. BIRD SM
    Trial size, HIV pre-exposure prophylaxis, and breastfeeding.
    Lancet. 2016;387:2090-1.
    PubMed     Text format    


  91. SHAPIRO R, Dryden-Peterson S, Powis K, Zash R, et al
    Hidden in plain sight: HIV, antiretrovirals, and stillbirths.
    Lancet. 2016;387:1994-1995.
    PubMed     Text format    


  92. MOKDAD AH, Forouzanfar MH, Daoud F, Mokdad AA, et al
    Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016 May 9. pii: S0140-6736(16)00648.
    PubMed     Text format     Abstract available


    April 2016
  93. ADAMS P
    Cryptococcal meningitis: a blind spot in curbing AIDS.
    Lancet. 2016;387:1605-6.
    PubMed     Text format    


  94. SNYDER A
    Willard Cates, Jr.
    Lancet. 2016;387:1506.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: